Key Growth Drivers Shaping the Antiarrhythmic Drugs Market
Cardiovascular disease remains the leading cause of death globally, and arrhythmias are among its most consequential manifestations. The antiarrhythmic drug sector is responding with expanded portfolios and targeted innovation, making it one of the more dynamic segments in cardiovascular pharmaceuticals. A primary driver of the antiarrhythmic drugs market is the growing prevalence of atrial...
0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior